Publications by authors named "P H Kluin"

Pathology plays a central role in the diagnosis of systemic mastocytosis (SM), its delineation from other neoplasms and reactive conditions, and in monitoring of SM under therapy. The morphologic hallmark of SM is the accumulation of spindle-shaped, hypogranulated mast cells (MCs) in bone marrow (BM) and other extracutaneous tissues. Four of the 5 World Health Organization-defined diagnostic criteria (ie, compact MC aggregates [=major criterion]; atypical MC morphology; activating KIT point mutations; aberrant expression of CD25 and/or CD2 and/or CD30 in MCs [=minor criteria]) can be addressed by the pathologist.

View Article and Find Full Text PDF

We present a case of an adult male with a solitary mast cell tumor of the skin with unusual nuclear pleomorphism and mitotic activity. The tumor was excised, recurred within 2 years, was reexcised after 4 years and did not recur >6 years after diagnosis. The tumor showed progressive cytonuclear atypia and a high mitotic and proliferation rate by Ki67-staining from the onset.

View Article and Find Full Text PDF
Article Synopsis
  • Patients with core-binding factor (CBF) acute myeloid leukemia (AML) show better remission rates and longer survival compared to other AML subtypes, but around 40% still experience relapse.
  • A study of 537 CBF-AML patients revealed important differences in cytogenetic abnormalities between those with two specific genetic mutations: patients with inv(16) had more trisomies while those with t(8;21) had higher rates of certain deletions.
  • Multivariable analyses indicated that specific chromosomal abnormalities could impact survival outcomes differently for these two mutations, with trisomy 8 benefiting patients with inv(16) and hypodiploidy improving outcomes for those with t(8;21).
View Article and Find Full Text PDF

Chromosomal breakpoints involving the MYC gene locus, frequently referred to as MYC rearrangements (MYC - R+), are a diagnostic hallmark of Burkitt lymphoma and recurrent in many other subtypes of B-cell lymphomas including follicular lymphoma, diffuse large B-cell lymphoma and other high-grade B-cell lymphomas and are associated with an aggressive clinical course. In remarkable contrast, in MCL, only few MYC - R+ cases have yet been described. In the current study, we have retrospectively analysed 16 samples (MYC - R+, n = 15, MYC - R-, n = 1) from 13 patients and describe their morphological, immunophenotypic and (molecular) genetic features and clonal evolution patterns.

View Article and Find Full Text PDF